Therapeutic Effects of Hemerocallis citrina Baroni Extract on Animal Models of Neurodegenerative Diseases Through Serotonin and HLH-30/TFEB Dependent Mechanisms
Authors:
- Jorge H FernandesJorge H Fernandes
- Marta Daniela CostaMCMarta Daniela Costa
- Daniela Vilasboas-CamposDVDaniela Vilasboas-Campos
- Joana Pereira-SousaJoana Pereira-Sousa
- Bruna Ferreira-LombaBFBruna Ferreira-Lomba
- Qiong WangQWQiong Wang
- Andreia Teixeira-CastroAndreia Teixeira-Castro
- Xinmin LiuXLXinmin Liu
- Fengzhong WangFWFengzhong Wang
- Alberto C. P. DiasAlberto C. P. Dias
- Patrícia MacielPatrícia Maciel
Preprint
- 30 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Hemerocallis citrina is an herbaceous perennial plant used in Asian cuisine and in Traditional Chinese Medicine. Here, we tested the therapeutic potential for a extracts (HCE30%, HCE50% and HCN) in vivo, using models of two human genetic neurodegenerative diseases – Machado-Joseph Disease/Spinocerebellar Ataxia type 3 and Frontotemporal Dementia with Parkinsonism associated to chromosome 17. Chronic treatment with HCE30% extract ameliorated the motor deficits typically observed in these models. Interestingly, we found that the effect on the motor phenotype of the MJD/SCA3 model was dependent on serotonergic signalling and on the action of the HLH-30/TFEB transcription factor, known to regulate the cellular response to amino acid starvation, the autophagy and mitophagy pathways, lysosome localization and biogenesis, exocytosis and mitochondrial biogenesis. Altogether, our findings reinforce the idea that phytochemicals act through the modulation of serotonergic neurotransmission and introduce a novel layer to the HLH-30/TFEB regulatory network. Thus, also strengthen the use of these pathways as therapeutic targets for protein-related neurodegenerative disorders and confirm the utility of medicinal plants as a source of innovation, in the quest for new therapeutic agents.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Qualitative and quantitative analysis of the components in flowers of Hemerocallis citrina Baroni by UHPLC–Q-TOF-MS/MS and UHPLC–QQQ-MS/MS and evaluation of their antioxidant activitiesJournal of Food Composition and Analysis, 2023
- Pathways to healing: Plants with therapeutic potential for neurodegenerative diseasesIBRO Neuroscience Reports, 2023
- Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph diseaseNeurobiology of Disease, 2021
- Transcription factor EB: an emerging drug target for neurodegenerative disordersDrug Discovery Today, 2021
- Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: Role of the glutathione redox cycleFree Radical Biology and Medicine, 2021
- The Autophagy–Lysosomal Pathway in Neurodegeneration: A TFEB PerspectiveTrends in Neurosciences, 2016
- Innate Host Defense Requires TFEB-Mediated Transcription of Cytoprotective and Antimicrobial GenesImmunity, 2014
- Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrinaJournal of Ethnopharmacology, 2012
- Structural basis of the anti-inflammatory activity of quercetin: inhibition of the 5-Hydroxytryptamine Type 2 ReceptorEuropean Biophysics Journal, 2009
- Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesisThe Lancet Neurology, 2004